Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee Kenvue’s business in the UK, Ireland, Norway, Sweden, Denmark and Finland.
Bas will manage a portfolio of iconic brands including Nicorette, Aveeno, Johnson’s Baby, Listerine, Neutrogena, Calpol, OGX and Imodium.
Carlton Lawson, Group President for Europe, Middle East, Africa and Latin America at Kenvue, said: “We are excited to welcome Bas as Area Managing Director for Kenvue in Northern Europe. With almost three decades of experience in consumer goods and healthcare, Bas brings a proven track record of delivering industry leading growth.”
Bas said: “Kenvue’s iconic brands speak for themselves. I am excited by the truly holistic approach to self-care we can offer through the entire range of different categories we thrive in.”
Prior to joining Kenvue, Bas held the position of Vice President & General Manager for Great Britain and Ireland at Haleon. He played a critical role in driving the GBI business, separating it from GSK while delivering industry-leading growth.
Bas was until recently President of the Board of the PAGB. He launched the organisation’s five-year strategy focusing on how the industry can support the government in alleviating healthcare pressures through promoting self-care.
Previously, Bas held several roles across Europe with GSK Consumer Healthcare, including VP & Head of Commercial Excellence EMEA, VP & General Manager France and French-speaking Africa & Maghreb, and GM Benelux. Prior to that, he held GM roles at Novartis. Bas started his career at Campina.
